Back to Search
Start Over
Combining EGFR and MET Inhibition With Crizotinib in EGFR-mutated Lung Adenocarcinoma Harboring MET Amplification: A Brief Report.
- Source :
-
Clinical lung cancer [Clin Lung Cancer] 2020 Nov; Vol. 21 (6), pp. e601-e606. Date of Electronic Publication: 2020 May 23. - Publication Year :
- 2020
- Subjects :
- Acrylamides administration & dosage
Adenocarcinoma of Lung genetics
Adenocarcinoma of Lung pathology
Adult
Aged
Aniline Compounds administration & dosage
Brain Neoplasms genetics
Brain Neoplasms secondary
Crizotinib administration & dosage
ErbB Receptors antagonists & inhibitors
ErbB Receptors genetics
Female
Humans
Lung Neoplasms genetics
Lung Neoplasms pathology
Male
Middle Aged
Prognosis
Adenocarcinoma of Lung therapy
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Brain Neoplasms therapy
Lung Neoplasms therapy
Mutation
Proto-Oncogene Proteins c-met antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1938-0690
- Volume :
- 21
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Clinical lung cancer
- Publication Type :
- Academic Journal
- Accession number :
- 32620469
- Full Text :
- https://doi.org/10.1016/j.cllc.2020.05.015